UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 202

Sortiert nach

Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D

Journal of lipid research, 2019-08, Vol.60 (8), p.1432-1439

2019

Volltextzugriff (PDF)

Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D

Journal of lipid research, 2018-05, Vol.59 (5), p.872-883

2018

Volltextzugriff (PDF)

The concept of apolipoprotein-defined lipoprotein families and its clinical significance

Current atherosclerosis reports, 2003-11, Vol.5 (6), p.459-467

Alaupovic, Petar

2003

Volltextzugriff (PDF)

Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease

The New England journal of medicine, 2001-11, Vol.345 (22), p.1583-1592

2001

Volltextzugriff (PDF)

Oxidative stress and inflammation in renal patients and healthy subjects

PloS one, 2011-07, Vol.6 (7), p.e22360-e22360

2011

Volltextzugriff (PDF)

Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo

Journal of lipid research, 2009-05, Vol.50 (5), p.894-907

2009

Volltextzugriff (PDF)

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE) trial

Circulation (New York, N.Y.), 2000-10, Vol.102 (16), p.1886-1892

2000

Volltextzugriff (PDF)

LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans

Lipids in health and disease, 2018-05, Vol.17 (1), p.127-127, Article 127

2018

Volltextzugriff (PDF)

Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia

Journal of clinical lipidology, 2015-05, Vol.9 (3), p.360-367

2015

Volltextzugriff (PDF)

Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat

Journal of clinical lipidology, 2013-03, Vol.7 (2), p.132-139

2013

Volltextzugriff (PDF)

[2] Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins

Methods in Enzymology, 1996, Vol.263, p.32-60

Alaupovic, Petar

1996

Volltextzugriff (PDF)

Effect of Peroxisome Proliferator-Activated Receptor γ Agonist Treatment on Subclinical Atherosclerosis in Patients With Insulin-Requiring Type 2 Diabetes

Diabetes care, 2006-07, Vol.29 (7), p.1545-1553

2006

Volltextzugriff (PDF)

Body Mass Index and Apolipoproteins C-III, B, and A-I in Young Adult Cherokee

Journal of clinical lipidology, 2015-05, Vol.9 (3), p.426-426

2015

Volltextzugriff (PDF)

Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes

Journal of clinical lipidology, 2013-01, Vol.7 (1), p.38-42

2013

Volltextzugriff (PDF)

Apolipoprotein C-I induces apoptosis in human aortic smooth muscle cells via recruiting neutral sphingomyelinase

Arteriosclerosis, thrombosis, and vascular biology, 2004-02, Vol.24 (2), p.264

2004

Volltextzugriff (PDF)

The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial

Arteriosclerosis, thrombosis, and vascular biology, 1997-04, Vol.17 (4), p.715

1997

Volltextzugriff (PDF)

Interrelationships between the concentration and size of the largest high-density lipoprotein subfraction and apolipoprotein C-I in infants at birth and follow-up at 2–3 months of age and their parents

Journal of clinical lipidology, 2013-01, Vol.7 (1), p.29-37

2013

Volltextzugriff (PDF)

Influence of Peripheral Artery Disease and Statin Therapy on Apolipoprotein Profiles

International Journal of Vascular Medicine, 2013-01, Vol.2013, p.548764-7

2013

Volltextzugriff (PDF)

Sex differences in HDL ApoC-III in American Indian youth

Biology of sex differences, 2012-08, Vol.3 (1), p.18-18

2012

Volltextzugriff (PDF)

Beef in an Optimal Lean Diet study: effects on lipids, lipoproteins, and apolipoproteins

The American journal of clinical nutrition, 2012-01, Vol.95 (1), p.9-16

2012

Volltextzugriff (PDF)

Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis

Kidney international, 1999-04, Vol.55 (4), p.1536-1542

1999

Volltextzugriff (PDF)

Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study

The American journal of clinical nutrition, 2008-09, Vol.88 (3), p.651-659

2008

Volltextzugriff (PDF)

Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study)

Journal of hypertension, 2003-08, Vol.21 (8), p.1563-1574

2003

Volltextzugriff (PDF)

High-Dose B Vitamin Supplementation and Progression of Subclinical Atherosclerosis : A Randomized Controlled Trial

Stroke (1970), 2009-03, Vol.40 (3), p.730-736

2009

Volltextzugriff (PDF)

Apolipoprotein‐Containing Lipoprotein Subclasses and Subclinical Atherosclerosis in Systemic Lupus Erythematosus

Arthritis Care & Research, 2015-03, Vol.67 (3), p.442-446

2015

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)
Mit Volltextzugriff
(133)

Publikationsform

Artikel
(202)

Sprache

Englisch
(201)
Japanisch
(29)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D

Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D

The concept of apolipoprotein-defined lipoprotein families and its clinical significance

Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease

Oxidative stress and inflammation in renal patients and healthy subjects

Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE) trial

LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans

Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia

Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat

[2] Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins

Effect of Peroxisome Proliferator-Activated Receptor γ Agonist Treatment on Subclinical Atherosclerosis in Patients With Insulin-Requiring Type 2 Diabetes

Body Mass Index and Apolipoproteins C-III, B, and A-I in Young Adult Cherokee

Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes

Apolipoprotein C-I induces apoptosis in human aortic smooth muscle cells via recruiting neutral sphingomyelinase

The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial

Interrelationships between the concentration and size of the largest high-density lipoprotein subfraction and apolipoprotein C-I in infants at birth and follow-up at 2–3 months of age and their parents

Influence of Peripheral Artery Disease and Statin Therapy on Apolipoprotein Profiles

Sex differences in HDL ApoC-III in American Indian youth

Beef in an Optimal Lean Diet study: effects on lipids, lipoproteins, and apolipoproteins

Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis

Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study

Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study)

High-Dose B Vitamin Supplementation and Progression of Subclinical Atherosclerosis : A Randomized Controlled Trial

Apolipoprotein‐Containing Lipoprotein Subclasses and Subclinical Atherosclerosis in Systemic Lupus Erythematosus

Suchergebnisse filtern